Atlas Trials

Feng Wang

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Feng Wang

RecordFirmDate
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer (NCT06682247)Feng Wang2024-11-15
Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell (NCT05049681)Feng Wang2021-12-05
Anlotinib Retrospective Study for Esophageal Cancer (NCT05303740)Feng Wang2019-01-01

Track Feng Wang automatically

Every clearance here is in the API, with alerts when new ones post.